Accuracy and Challenges in the Vesical Imaging‐Reporting and Data System for Staging Bladder Cancer

Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BC...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 56; no. 2; pp. 391 - 398
Main Authors Meng, Xiaoyan, Hu, Henglong, Wang, Yanchun, Feng, Cui, Hu, Daoyu, Liu, Zheng, Kamel, Ihab R., Li, Zhen
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence. Study Type Retrospective. Subjects A total of 106 patients (include 16.5% female) with bladder cancer. Sequence T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo). Assessment Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards. Statistical Tests Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant. Results Fourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value. Data conclusion The DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients. Evidence Level 4 Technical Efficacy Stage 3
AbstractList The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.BACKGROUNDThe Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.To describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence.PURPOSETo describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence.Retrospective.STUDY TYPERetrospective.A total of 106 patients (include 16.5% female) with bladder cancer.SUBJECTSA total of 106 patients (include 16.5% female) with bladder cancer.T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).SEQUENCET2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.ASSESSMENTSome cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.STATISTICAL TESTSReceiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.Fourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.RESULTSFourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.The DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients.DATA CONCLUSIONThe DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients.4 TECHNICAL EFFICACY: Stage 3.EVIDENCE LEVEL4 TECHNICAL EFFICACY: Stage 3.
Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence. Study Type Retrospective. Subjects A total of 106 patients (include 16.5% female) with bladder cancer. Sequence T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo). Assessment Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards. Statistical Tests Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant. Results Fourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value. Data conclusion The DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients. Evidence Level 4 Technical Efficacy Stage 3
The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. To describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence. Retrospective. A total of 106 patients (include 16.5% female) with bladder cancer. T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo). Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards. Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant. Fourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value. The DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients. 4 TECHNICAL EFFICACY: Stage 3.
BackgroundThe Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.PurposeTo describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence.Study TypeRetrospective.SubjectsA total of 106 patients (include 16.5% female) with bladder cancer.SequenceT2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).AssessmentSome cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.Statistical TestsReceiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.ResultsFourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.Data conclusionThe DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients.Evidence Level4Technical EfficacyStage 3
Author Feng, Cui
Li, Zhen
Wang, Yanchun
Hu, Henglong
Meng, Xiaoyan
Liu, Zheng
Kamel, Ihab R.
Hu, Daoyu
Author_xml – sequence: 1
  givenname: Xiaoyan
  orcidid: 0000-0002-3424-6928
  surname: Meng
  fullname: Meng, Xiaoyan
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 2
  givenname: Henglong
  surname: Hu
  fullname: Hu, Henglong
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 3
  givenname: Yanchun
  surname: Wang
  fullname: Wang, Yanchun
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 4
  givenname: Cui
  orcidid: 0000-0001-9719-8436
  surname: Feng
  fullname: Feng, Cui
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 5
  givenname: Daoyu
  surname: Hu
  fullname: Hu, Daoyu
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 6
  givenname: Zheng
  surname: Liu
  fullname: Liu, Zheng
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 7
  givenname: Ihab R.
  orcidid: 0000-0003-0511-7796
  surname: Kamel
  fullname: Kamel, Ihab R.
  organization: the Johns Hopkins Medical Institutions
– sequence: 8
  givenname: Zhen
  orcidid: 0000-0001-8037-4245
  surname: Li
  fullname: Li, Zhen
  email: zhenli@hust.edu.cn
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35049074$$D View this record in MEDLINE/PubMed
BookMark eNp90ctu1DAUBmALFdELbHgAZIkNqpTixLdkWYYCg4qQWmAbnTjHU48cZ2o7QrPjEXhGnoR0prCoECufxfcfHfk_JgdhDEjI85KdlYxVr9dDdGdVzZR4RI5KWVVFJWt1MM9M8qKsmT4kxymtGWNNI-QTcsglEw3T4ojguTFTBLOlEHq6uAHvMawwURdovkH6DZMz4OlygJULq18_fl7hZox5nneJt5CBXm9TxoHaMdLrvHP0jYe-x0gXEAzGp-SxBZ_w2f17Qr6-u_iy-FBcfn6_XJxfFkZUXBScG9tIZlTPrJDAFLcN77DTyK1hiJ0A6JUCqxtpUVe2FqI3qkMFopZ9w0_Iq_3eTRxvJ0y5HVwy6D0EHKfUVqoqlWw01zN9-YCuxymG-bpZ1VpppWQ9qxf3auoG7NtNdAPEbfvnA2dwugcmjilFtH9Jydq7dtq7dtpdOzNmD7BxGbIbQ47g_L8j5T7y3Xnc_md5-_HT1XKf-Q2UBqJx
CitedBy_id crossref_primary_10_3390_cancers14133181
crossref_primary_10_1007_s00330_023_09960_y
crossref_primary_10_1259_bjr_20230239
crossref_primary_10_1016_j_acra_2024_07_002
crossref_primary_10_1016_j_clgc_2022_03_002
crossref_primary_10_3390_diagnostics14040442
crossref_primary_10_1007_s00261_024_04245_4
crossref_primary_10_1007_s00261_024_04658_1
crossref_primary_10_1016_j_clinimag_2024_110279
Cites_doi 10.1148/radiol.2019182506
10.1007/s00330-020-07153-5
10.1007/s00330-020-06802-z
10.2214/AJR.20.23604
10.1080/2090598X.2020.1733818
10.1002/jmri.27141
10.1016/j.ejrad.2020.109486
10.1016/j.eururo.2020.03.055
10.1016/j.eururo.2018.09.001
10.1007/s00330-019-06117-8
10.1016/j.eururo.2018.04.029
10.1016/j.eururo.2019.09.029
10.1259/bjr.20190401
10.1002/jmri.27361
10.1007/s00330-017-4758-3
10.1148/rg.287075154
10.1016/j.eururo.2019.08.016
10.1007/s00261-019-02190-1
10.21037/tau.2020.02.16
10.1007/s00261-018-1458-7
10.1002/jmri.26294
10.2214/AJR.20.22763
10.1148/radiol.2017171028
10.1016/j.euo.2020.02.007
10.1007/s00261-018-1614-0
10.1097/MD.0000000000002951
10.1007/s00330-020-07224-7
10.1016/j.eururo.2019.03.012
10.1007/s00330-020-07473-6
10.2463/mrms.2013-0104
10.3390/cancers12102994
ContentType Journal Article
Copyright 2022 International Society for Magnetic Resonance in Medicine.
2022 International Society for Magnetic Resonance in Medicine
Copyright_xml – notice: 2022 International Society for Magnetic Resonance in Medicine.
– notice: 2022 International Society for Magnetic Resonance in Medicine
DBID AAYXX
CITATION
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
DOI 10.1002/jmri.28064
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 398
ExternalDocumentID 35049074
10_1002_jmri_28064
JMRI28064
Genre article
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 82102025; 82071889; 81771801
– fundername: National Natural Science Foundation of China
  grantid: 81771801
– fundername: National Natural Science Foundation of China
  grantid: 82102025
– fundername: National Natural Science Foundation of China
  grantid: 82071889
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QO
7TK
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c4234-33cf950c6d0f45a063f93beb7e3fc0eeb4aad66af795fe72f844dc6be6a485d93
IEDL.DBID DR2
ISSN 1053-1807
1522-2586
IngestDate Thu Jul 10 19:29:03 EDT 2025
Fri Jul 25 12:20:01 EDT 2025
Wed Feb 19 02:26:57 EST 2025
Tue Jul 01 03:56:52 EDT 2025
Thu Apr 24 23:12:45 EDT 2025
Wed Jan 22 16:23:41 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords multiparametric MRI
Vesical Imaging-Reporting Data System
diffusion-weighted imaging
staging
bladder cancer
Language English
License 2022 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4234-33cf950c6d0f45a063f93beb7e3fc0eeb4aad66af795fe72f844dc6be6a485d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3424-6928
0000-0001-8037-4245
0000-0001-9719-8436
0000-0003-0511-7796
PMID 35049074
PQID 2687676658
PQPubID 1006400
PageCount 8
ParticipantIDs proquest_miscellaneous_2621659737
proquest_journals_2687676658
pubmed_primary_35049074
crossref_primary_10_1002_jmri_28064
crossref_citationtrail_10_1002_jmri_28064
wiley_primary_10_1002_jmri_28064_JMRI28064
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2022
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: August 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2018; 286
2019; 92
2019; 291
2019; 76
2017; 27
2016; 95
2020; 12
2020; 77
2020; 55
2018; 43
2018; 48
2020; 18
2021; 79
2021; 31
2020; 3
2020; 31
2020; 30
2020; 52
2021; 136
2021; 216
2020; 9
2008; 28
2020; 214
2019; 29
2014; 13
2018; 74
2020; 45
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_30_1
References_xml – volume: 216
  start-page: 1257
  issue: 5
  year: 2021
  end-page: 1266
  article-title: VI‐RADS: Multiinstitutional multireader diagnostic accuracy and interobserver agreement study
  publication-title: AJR Am J Roentgenol
– volume: 77
  start-page: 101
  issue: 1
  year: 2020
  end-page: 109
  article-title: Prospective assessment of Vesical Imaging Reporting and Data System (VI‐RADS) and its clinical impact on the management of high‐risk non‐muscle‐invasive bladder cancer patients candidate for repeated transurethral resection
  publication-title: Eur Urol
– volume: 79
  start-page: 82
  issue: 1
  year: 2021
  end-page: 104
  article-title: European Association of Urology guidelines on muscle‐invasive and metastatic bladder cancer: Summary of the 2020 guidelines
  publication-title: Eur Urol
– volume: 31
  start-page: 1656
  year: 2020
  end-page: 1666
  article-title: Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging‐reporting and data system
  publication-title: Eur Radiol
– volume: 92
  issue: 1104
  year: 2019
  article-title: Multiparametric MRI in differentiation between muscle invasive and non‐muscle invasive urinary bladder cancer with Vesical Imaging Reporting and Data System (VI‐RADS) application
  publication-title: Br J Radiol
– volume: 9
  start-page: 445
  issue: 2
  year: 2020
  end-page: 451
  article-title: Evaluation of vesical imaging‐reporting and data system (VI‐RADS) scoring system in predicting muscle invasion of bladder cancer
  publication-title: Transl Androl Urol
– volume: 12
  start-page: 2994
  issue: 10
  year: 2020
  article-title: Systematic review and meta‐analysis of vesical imaging‐reporting and data system (VI‐RADS) inter‐observer reliability: An added value for muscle invasive bladder cancer detection
  publication-title: Cancers (Basel)
– volume: 214
  start-page: 1259
  issue: 6
  year: 2020
  end-page: 1268
  article-title: Overview of VI‐RADS in bladder cancer
  publication-title: AJR Am J Roentgenol
– volume: 3
  start-page: 306
  issue: 3
  year: 2020
  end-page: 315
  article-title: Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle‐invasive bladder cancer: A systematic review and meta‐analysis
  publication-title: Eur Urol Oncol
– volume: 18
  start-page: 67
  issue: 2
  year: 2020
  end-page: 71
  article-title: The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging‐Reporting and Data System): A systematic review
  publication-title: Arab J Urol
– volume: 286
  start-page: 502
  issue: 2
  year: 2018
  end-page: 511
  article-title: The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta‐analysis
  publication-title: Radiology
– volume: 28
  start-page: 1983
  issue: 7
  year: 2008
  end-page: 1998
  article-title: 3.0‐T MR imaging of the abdomen: Comparison with 1.5 T
  publication-title: Radiographics
– volume: 29
  start-page: 5498
  issue: 10
  year: 2019
  end-page: 5506
  article-title: Multiparametric MRI of the bladder: Inter‐observer agreement and accuracy with the Vesical Imaging‐Reporting and Data System (VI‐RADS) at a single reference center
  publication-title: Eur Radiol
– volume: 45
  start-page: 491
  issue: 2
  year: 2020
  end-page: 498
  article-title: Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor
  publication-title: Abdom Radiol (NY)
– volume: 13
  start-page: 175
  issue: 3
  year: 2014
  end-page: 181
  article-title: Preoperative T staging of urinary bladder cancer: Efficacy of stalk detection and diagnostic performance of diffusion‐weighted imaging at 3T
  publication-title: Magn Reson Med Sci
– volume: 48
  start-page: 882
  issue: 4
  year: 2018
  end-page: 896
  article-title: Update on multiparametric MRI of urinary bladder cancer
  publication-title: J Magn Reson Imaging
– volume: 31
  start-page: 875
  year: 2020
  end-page: 883
  article-title: Clinical utility of the Vesical Imaging‐Reporting and Data System for muscle‐invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2‐weighted acquisitions
  publication-title: Eur Radiol
– volume: 52
  start-page: 1249
  issue: 4
  year: 2020
  end-page: 1256
  article-title: Vesical imaging‐reporting and data system for multiparametric MRI to predict the presence of muscle invasion for bladder cancer
  publication-title: J Magn Reson Imaging
– volume: 95
  issue: 10
  year: 2016
  article-title: Nonmuscle‐invasive and muscle‐invasive urinary bladder cancer
  publication-title: Medicine
– volume: 76
  start-page: 54
  issue: 1
  year: 2019
  end-page: 56
  article-title: Diagnostic accuracy and interobserver agreement for the Vesical Imaging‐Reporting and Data System for muscle‐invasive bladder cancer: A multireader validation study
  publication-title: Eur Urol
– volume: 74
  start-page: 784
  issue: 6
  year: 2018
  end-page: 795
  article-title: Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018
  publication-title: Eur Urol
– volume: 74
  start-page: 294
  issue: 3
  year: 2018
  end-page: 306
  article-title: Multiparametric magnetic resonance imaging for bladder cancer: Development of VI‐RADS (Vesical Imaging‐Reporting And Data System)
  publication-title: Eur Urol
– volume: 30
  start-page: 4606
  issue: 8
  year: 2020
  end-page: 4614
  article-title: Use of vesical imaging‐reporting and data system (VI‐RADS) for detecting the muscle invasion of bladder cancer: A diagnostic meta‐analysis
  publication-title: Eur Radiol
– volume: 55
  start-page: 23
  year: 2020
  end-page: 36
  article-title: VI‐RADS for bladder cancer: Current applications and future developments
  publication-title: J Magn Reson Imaging
– volume: 31
  start-page: 3874
  issue: 6
  year: 2021
  end-page: 3883
  article-title: Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi‐reader VI‐RADS approach
  publication-title: Eur Radiol
– volume: 291
  start-page: 668
  issue: 3
  year: 2019
  end-page: 674
  article-title: Multiparametric MRI for bladder cancer: Validation of VI‐RADS for the detection of detrusor muscle invasion
  publication-title: Radiology
– volume: 136
  year: 2021
  article-title: Application of bi‐planar reduced field‐of‐view DWI (rFOV DWI) in the assessment of muscle‐invasiveness of bladder cancer
  publication-title: Eur J Radiol
– volume: 76
  start-page: 639
  issue: 5
  year: 2019
  end-page: 657
  article-title: European Association of Urology guidelines on non‐muscle‐invasive bladder cancer (TaT1 and carcinoma in situ) ‐ 2019 update
  publication-title: Eur Urol
– volume: 43
  start-page: 2431
  issue: 9
  year: 2018
  end-page: 2441
  article-title: Diagnostic performance of diffusion‐weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: Utility of evaluating the morphology of the reactive tumor stalk
  publication-title: Abdom Radiol
– volume: 27
  start-page: 3759
  issue: 9
  year: 2017
  end-page: 3766
  article-title: An evaluation of morphological and functional multi‐parametric MRI sequences in classifying non‐muscle and muscle invasive bladder cancer
  publication-title: Eur Radiol
– volume: 43
  start-page: 3509
  issue: 12
  year: 2018
  end-page: 3510
  article-title: "Inchworm sign" in urinary bladder cancer
  publication-title: Abdom Radiol (NY)
– ident: e_1_2_8_8_1
  doi: 10.1148/radiol.2019182506
– ident: e_1_2_8_20_1
  doi: 10.1007/s00330-020-07153-5
– ident: e_1_2_8_18_1
  doi: 10.1007/s00330-020-06802-z
– ident: e_1_2_8_14_1
  doi: 10.2214/AJR.20.23604
– ident: e_1_2_8_13_1
  doi: 10.1080/2090598X.2020.1733818
– ident: e_1_2_8_21_1
  doi: 10.1002/jmri.27141
– ident: e_1_2_8_23_1
  doi: 10.1016/j.ejrad.2020.109486
– ident: e_1_2_8_2_1
  doi: 10.1016/j.eururo.2020.03.055
– ident: e_1_2_8_3_1
  doi: 10.1016/j.eururo.2018.09.001
– ident: e_1_2_8_9_1
  doi: 10.1007/s00330-019-06117-8
– ident: e_1_2_8_6_1
  doi: 10.1016/j.eururo.2018.04.029
– ident: e_1_2_8_11_1
  doi: 10.1016/j.eururo.2019.09.029
– ident: e_1_2_8_7_1
  doi: 10.1259/bjr.20190401
– ident: e_1_2_8_15_1
  doi: 10.1002/jmri.27361
– ident: e_1_2_8_29_1
  doi: 10.1007/s00330-017-4758-3
– ident: e_1_2_8_30_1
  doi: 10.1148/rg.287075154
– ident: e_1_2_8_4_1
  doi: 10.1016/j.eururo.2019.08.016
– ident: e_1_2_8_22_1
  doi: 10.1007/s00261-019-02190-1
– ident: e_1_2_8_16_1
  doi: 10.21037/tau.2020.02.16
– ident: e_1_2_8_25_1
  doi: 10.1007/s00261-018-1458-7
– ident: e_1_2_8_28_1
  doi: 10.1002/jmri.26294
– ident: e_1_2_8_27_1
  doi: 10.2214/AJR.20.22763
– ident: e_1_2_8_5_1
  doi: 10.1148/radiol.2017171028
– ident: e_1_2_8_32_1
  doi: 10.1016/j.euo.2020.02.007
– ident: e_1_2_8_24_1
  doi: 10.1007/s00261-018-1614-0
– ident: e_1_2_8_31_1
  doi: 10.1097/MD.0000000000002951
– ident: e_1_2_8_19_1
  doi: 10.1007/s00330-020-07224-7
– ident: e_1_2_8_10_1
  doi: 10.1016/j.eururo.2019.03.012
– ident: e_1_2_8_12_1
  doi: 10.1007/s00330-020-07473-6
– ident: e_1_2_8_26_1
  doi: 10.2463/mrms.2013-0104
– ident: e_1_2_8_17_1
  doi: 10.3390/cancers12102994
SSID ssj0009945
Score 2.4382968
Snippet Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To...
The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. To describe the...
BackgroundThe Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.PurposeTo...
The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.BACKGROUNDThe Vesical...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 391
SubjectTerms Bladder
Bladder cancer
Cancer
Correlation coefficient
Correlation coefficients
Diagnostic systems
diffusion‐weighted imaging
Histopathology
Invasiveness
Magnetic resonance imaging
Medical imaging
multiparametric MRI
Muscles
Performance evaluation
Sequences
staging
Statistical analysis
Statistical tests
Vesical Imaging‐Reporting Data System
Title Accuracy and Challenges in the Vesical Imaging‐Reporting and Data System for Staging Bladder Cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.28064
https://www.ncbi.nlm.nih.gov/pubmed/35049074
https://www.proquest.com/docview/2687676658
https://www.proquest.com/docview/2621659737
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh6oXSmmhCxS5ai9FypL4GUu9wFIESNsDAsQFRbZjS7QQUHb30J74CfzG_pKOnceKtkJqL5GljB_xjO3PGfsbhD5ww01quYC9CYWHy32iiC4TIkiu4Z1kOtwdHn8Rh2fs-IJfLKBP3V2Yhh-i_-EWRkacr8MA12ayMycN_XpTXw2DXzCQgYbDWgERncy5o5SKEYoBP9Aky1PZc5OSnXnWx6vRHxDzMWKNS87BC3TZNbY5afJtOJuaof3xG4_j_37NMlpqsSjebYznJVpw1Qp6Nm697a-Q27V2Vmv7HeuqxKMu7MoEX1UYcCM-d1HF-Ogmhjr6ef_QwHlIxxz7eqpxQ4mOARtjALZBDu9dh-muxqNgcfVrdHbw-XR0mLRhGRIL2IsllFqveGpFmXrGNWAcr6hxRjrqbeqcAfWWQmgvFfdOEp8zVlphnNAs56Wiq2ixuq3cG4Qp4CtipXHKMwal6VJlJHPKpdpkQssB-tipp7AtZ3kInXFdNGzLpAj9VsR-G6D3vexdw9TxV6nNTstFO1onBRGwJkgBYGyA3vWvYZwF54mu3O0syJBMwO6LQqPWGuvoq6E8-E8lFL4ddfxE_cXx-OQoptb_RXgDPSfh3kU8ebiJFqf1zL0FNDQ1W9HqfwG-Awak
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PTxQxFG8QEvWi4t8F1Bq9aDLLTP9Oj7hAdoHlQMBwm7SdNkFhMLO7Bz3xEfiMfBJeO7OzQY2JXiZN5rWd6etrf-1rfw-hD9xwk1ouYG1C4eFynyiiy4QIkmt4J5kOd4fHh2J4wvZO-Wl7NifchWn4IboNt2AZcbwOBh42pDcXrKFfL-qzfnAMsntoJYT0jiuqowV7lFIxRjEgCJpkeSo7dlKyuch7dz76DWTexaxx0tl93ERWnUSuwnDW5Ft_NjV9-_MXJsf__p8n6FELR_FW039W0ZKrnqL749bh_gy5LWtntbY_sK5KPJhHXpngswoDdMRfXNQyHl3EaEc3V9cNood0zLGtpxo3rOgY4DEGbBvk8OfzMOLVeBA6Xf0cnezuHA-GSRuZIbEAv1hCqfWKp1aUqWdcA8zxihpnpKPeps4Z0HAphPZSce8k8TljpRXGCc1yXir6Ai1Xl5V7hTAFiEWsNE55xqA0XaqMZE65VJtMaNlDH-f6KWxLWx6iZ5wXDeEyKUK7FbHdeuh9J_u9Iev4o9TGXM1Fa7CTggiYFqQAPNZD77rXYGrBf6IrdzkLMiQTsACj8FEvm-7RVUN5cKFKKPxTVPJf6i_2xkejmFr7F-G36MHweHxQHIwO99fRQxKuYcSDiBtoeVrP3GsAR1PzJprALRYlCr8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSouUN4LBYzgAlK2iZ-xxKXssuoWtkIVRb2gyHZsqdCmVbp7gBM_ob-xv6Rj57EqICS4RJYyfsTjsT9n7G8QeskNN6nlAvYmFB4u94kiukyIILmGd5LpcHd4tiu299nOAT9YQW-6uzANP0T_wy1YRpyvg4Gfln5zSRr69bg-HAa_ILuGrjOR5mFMj_eW5FFKxRDFACBokuWp7MlJyeYy79Xl6DeMeRWyxjVncgt96VrbHDX5NlzMzdD--IXI8X8_Zx3dbMEo3mpGz2204qo7aG3WutvvIrdl7aLW9jvWVYlHXdyVM3xYYQCO-LOLOsbT4xjr6OLneYPnIR1zjPVc44YTHQM4xoBsgxx-exTmuxqPwpCr76H9ybtPo-2kjcuQWABfLKHUesVTK8rUM64B5HhFjTPSUW9T5wzotxRCe6m4d5L4nLHSCuOEZjkvFb2PVquTyj1EmALAIlYapzxjUJouVUYyp1yqTSa0HKBXnXoK25KWh9gZR0VDt0yK0G9F7LcBetHLnjZUHX-U2ui0XLTmelYQAYuCFIDGBuh5_xoMLXhPdOVOFkGGZAK2XxQa9aAZHX01lAcHqoTCX0cd_6X-Yme2N42pR_8i_AytfRxPig_T3feP0Q0S7mDEU4gbaHVeL9wTQEZz8zQawCURBAl3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+and+Challenges+in+the+Vesical+Imaging%E2%80%90Reporting+and+Data+System+for+Staging+Bladder+Cancer&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Meng%2C+Xiaoyan&rft.au=Hu%2C+Henglong&rft.au=Wang%2C+Yanchun&rft.au=Feng%2C+Cui&rft.date=2022-08-01&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=56&rft.issue=2&rft.spage=391&rft.epage=398&rft_id=info:doi/10.1002%2Fjmri.28064&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jmri_28064
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon